144 related articles for article (PubMed ID: 24505313)
1. A novel cellular senescence gene, SENEX, is involved in peripheral regulatory T cells accumulation in aged urinary bladder cancer.
Chen T; Wang H; Zhang Z; Li Q; Yan K; Tao Q; Ye Q; Xiong S; Wang Y; Zhai Z
PLoS One; 2014; 9(2):e87774. PubMed ID: 24505313
[TBL] [Abstract][Full Text] [Related]
2. Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness.
Winerdal ME; Krantz D; Hartana CA; Zirakzadeh AA; Linton L; Bergman EA; Rosenblatt R; Vasko J; Alamdari F; Hansson J; Holmström B; Johansson M; Winerdal M; Marits P; Sherif A; Winqvist O
Cancer Immunol Res; 2018 May; 6(5):528-538. PubMed ID: 29588320
[TBL] [Abstract][Full Text] [Related]
3. Stress-induced premature senescence activated by the SENEX gene mediates apoptosis resistance of diffuse large B-cell lymphoma via promoting immunosuppressive cells and cytokines.
Wang J; Tao Q; Pan Y; Wanyan Z; Zhu F; Xu X; Wang H; Yi L; Zhou M; Zhai Z
Immun Inflamm Dis; 2020 Dec; 8(4):672-683. PubMed ID: 33015970
[TBL] [Abstract][Full Text] [Related]
4. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
Krustrup D; Madsen CB; Iversen M; Engelholm L; Ryder LP; Andersen CB
Transpl Immunol; 2013 Dec; 29(1-4):71-5. PubMed ID: 23969200
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells.
Coleman PR; Hahn CN; Grimshaw M; Lu Y; Li X; Brautigan PJ; Beck K; Stocker R; Vadas MA; Gamble JR
Blood; 2010 Nov; 116(19):4016-24. PubMed ID: 20664062
[TBL] [Abstract][Full Text] [Related]
6. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
[TBL] [Abstract][Full Text] [Related]
7. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
Chi LJ; Wang HB; Zhang Y; Wang WZ
J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosis.
Yan X; Wu C; Chen T; Santos MM; Liu CL; Yang C; Zhang L; Ren J; Liao S; Guo H; Sukhova GK; Shi GP
Mol Immunol; 2017 Feb; 82():66-74. PubMed ID: 28033540
[TBL] [Abstract][Full Text] [Related]
9. Murine regulatory T cells induce death of effector T, B, and NK lymphocytes through a contact-independent mechanism involving telomerase suppression and telomere-associated senescence.
Zhdanov DD; Gladilina YA; Pokrovsky VS; Grishin DV; Grachev VA; Orlova VS; Pokrovskaya MV; Alexandrova SS; Sokolov NN
Cell Immunol; 2018 Sep; 331():146-160. PubMed ID: 29935763
[TBL] [Abstract][Full Text] [Related]
10. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
Valencia X; Yarboro C; Illei G; Lipsky PE
J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
12. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
13. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
[TBL] [Abstract][Full Text] [Related]
14. IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity.
Krantz D; Mints M; Winerdal M; Riklund K; Rutishauser D; Zubarev R; Zirakhzadeh AA; Alamdari F; Johansson M; Sherif A; Winqvist O
Scand J Immunol; 2020 Dec; 92(6):e12926. PubMed ID: 32862475
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
16. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
Huen NY; Pang AL; Tucker JA; Lee TL; Vergati M; Jochems C; Intrivici C; Cereda V; Chan WY; Rennert OM; Madan RA; Gulley JL; Schlom J; Tsang KY
Int J Cancer; 2013 Jul; 133(2):373-82. PubMed ID: 23319273
[TBL] [Abstract][Full Text] [Related]
19. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
[TBL] [Abstract][Full Text] [Related]
20. CD4
Zhang ZN; Bai LX; Fu YJ; Jiang YJ; Shang H
Cytokine; 2017 Mar; 91():110-117. PubMed ID: 28043029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
